MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2022 International Congress

    Vascular Causes of Atypical Parkinsonism Versus Vascular Contribution Towards Atypical Parkinsonism

    M K. Acharya (KHARAGPUR, India)

    Objective: In this study, we have compared the clinical features of atypical parkinsonism with high vascular load to find the difference between isolated vascular pathology…
  • 2022 International Congress

    Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy

    A. Quattrone, M. Crasà, M. Morelli, B. Vescio, A. Augimeri, V. Gramigna, A. Quattrone (Catanzaro, Italy)

    Objective: Objective: PSP patients typically show reduced amplitude and velocity of vertical saccades, but saccadic abnormalities have also been reported in PD. We investigated the…
  • 2022 International Congress

    Novel insights into the genetic basis of Indian patients with Progressive supranuclear palsy (PSP)

    S. Dey, M. Debnath, R. Yelamanchi, N. Kamble, V. Holla, P. Pal, R. Yadav (Bengaluru, India)

    Objective: To investigate the impact of four major risk genes, identified by genome-wide association studies (GWAS) in Indian patients with sporadic Progressive Supranuclear Palsy (PSP).…
  • 2022 International Congress

    Clinicopathologic features of corticobasal syndrome associated with corticobasal degeneration, progressive supranuclear palsy, Alzheimer’s disease, and FTLD-TDP

    S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)

    Objective: To compare the clinicopathologic features of corticobasal syndrome (CBS) associated with corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), Alzheimer's disease (AD), and frontotemporal lobar…
  • 2022 International Congress

    Substantia nigra dopaminergic neuron density in PD, PSP and MSA: An interim clinicopathological analysis

    E. Backman, L. Saari, M. Gardberg, V. Kaasinen (Turku, Finland)

    Objective: To investigate substantia nigra pars compacta (SNc) area together with dopaminergic neuron count and density in atypical parkinsonisms in relation to Parkinson’s disease (PD)…
  • 2022 International Congress

    Prevalence of Parkinson’s disease and Atypical Parkinsonisms in Colombia: Data from the national health registry 2016-2021

    G. Rincón, J. Torres-García, C. Pantoja-Ruiz, D. Rosselli (Bogotá, Colombia)

    Objective: To estimate prevalence of Parkinson’s Disease (PD) and Atypical Parkinsonisms and characterise the diagnosed population in a country with a development economy Background: The…
  • 2022 International Congress

    Gait and Balance Characteristics in Atypical Parkinsonian Syndromes

    V. Sidoroff, C. Raccagni, K. Seppi, H. Gassner, J. Winkler, N. Hergenröder-Lenzner, N. Roth, B. Eskofier, S. Buechner, D. Benninger, K. Aminian, G. Wenning (Innsbruck, Austria)

    Objective: To characterize a cohort of patients with multiple system atrophy (MSA) and progressive supranuclear gaze palsy compared to idiopathic Parkinson’s disease (IPD) patients according…
  • 2022 International Congress

    Retinal thickness as a marker of disease progression in progressive supranuclear palsy

    Y. Chen, H. Wang, B. Wang, B. Li, P. Ye, W. Xu, P. Liu, X. Chen, Z. Cen, Z. Ouyang, S. Wu, X. Dou, Y. Liao, W. Luo (Hangzhou, China)

    Objective: We measured changes of retinal thickness, and compare them with clinical features and intracranial neurodegeneration in progressive supranuclear palsy (PSP) cohort. Background: PSP has a…
  • 2022 International Congress

    A trail towards understanding cognitive impairment in PSP

    S. Kannenberg, A. Hausmann, C. Hartmann, J. Caspers, A. Schnitzler (Duesseldorf, Germany)

    Objective: To investigate cognitive impairment in 22 patients with Progressive Supranuclear Palsy with Richardson syndrome (PSP-RS). Background: PSP is a neurodegenerative disease and common differential…
  • 2022 International Congress

    APOE effect on Progressive Supranuclear Palsy phenotypes

    Y. Abida, I. Kacem, S. Mrabet, A. Gharbi, A. Souissi, A. Gargouri, A. Nasri, R. Gouider (Mannouba, Tunisia)

    Objective: To assess the influence of the Apolipoprotein E (APOE) gene variants on Progressive supranuclear palsy (PSP) phenotypic expression. Background: PSP is a rare neurodegenerative…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley